{
    "code": "02023485",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023485",
    "time": "2019-08-16 03:03:46",
    "許可證字號": "衛署藥輸字第023485號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/07\/01",
    "發證日期": "91\/07\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202348505",
    "中文品名": "黴息止注射劑50毫克",
    "英文品名": "CANCIDAS INJECTION 50MG",
    "適應症": "適用於其他治療方法無效或不能忍受的侵入性麴菌病(INVASIVE ASPERGILLOSIS)治療之第二線用藥，食道念珠菌感染。併有及未併有嗜中性白血球減少現象之患者得侵入性念珠菌感染症，包括念珠菌血症(INVASIVE CANDIDIASIS)。對發燒的重度嗜中性白血球缺乏症患者可能罹患黴菌感染症之經驗療法。",
    "劑型": "243凍晶注射劑",
    "包裝": "50公絲以下小瓶 100之以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "CASPOFUNGIN ( AS ACETATE)",
    "主製造廠": {
        "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
        "申請商地址": "台北市信義區信義路五段106號12樓",
        "主製造廠": "",
        "製造廠名稱": "FFR0054100  LABORATORIES MERCK SHARP &amp; DOHME-CHIBRET"
    },
    "CCC號列": "30042000211 人用醫藥製劑，含抗黴菌劑類抗生素者Medicaments, containing antifungal antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812204210",
            "成分名稱": "CASPOFUNGIN ( AS ACETATE)",
            "含量描述": "(55.5MG)",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020234850001-106-05-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023485&Seq=014&Type=9"
        },
        {
            "title": "Cancidas Injection 50mg Label-104-08-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023485&Seq=006&Type=8"
        }
    ]
}